ADVERSE EFFECTS OF TRENBOLONE: A STRUCTURED REVIEW OF CASE REPORTS IN HUMANS

Introduction: Trenbolone is a potent anabolic steroid widely used in bodybuilding, despite its lack of approval for human use. Reports of adverse effects have increased, but systematic data on its health risks remain limited. This study aims to systematically review documented adverse effects of trenbolone in humans through published case reports. Methods: A structured review of case reports was conducted using PubMed, EMBASE, and CENTRAL databases, including studies up to 2024. The search strategy utilized Medical Subject Headings (MeSH) terms related to trenbolone. Inclusion criteria encompassed reports of adverse effects in humans with documented trenbolone use, while experimental studies, animal models, and reviews without original case data were excluded. Extracted data included patient demographics, trenbolone dosage, administration patterns, clinical presentation, toxicological findings, and affected organ systems. Results: A total of 23 case reports met the inclusion criteria. The most frequently reported complications involved the cardiovascular system (heart failure, myocardial infarction, ischemic stroke), hepatic system (cholestatic liver injury, hepatitis), renal system (nephropathy, acute kidney injury), and neuropsychiatric effects (psychosis, aggression, delirium). Most cases involved young male users, with trenbolone frequently sourced from unregulated markets. Toxicological confirmation was reported in only a minority of cases, complicating causality assessment. Conclusion: Trenbolone use is associated with severe health risks, particularly affecting the cardiovascular, hepatic, renal, and neuropsychiatric systems. The absence of clinical studies on its safety, along with widespread unregulated use, hinders risk assessment and patient management. Healthcare professionals should recognize potential adverse effects, promoting early detection and harm reduction. Further research is needed to clarify trenbolone’s long-term impact on human health.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-30
DOI
https://doi.org/10.5281/zenodo.15108706
Primary Topic
Hormonal and reproductive studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ADVERSE EFFECTS OF TRENBOLONE: A STRUCTURED REVIEW OF CASE REPORTS IN HUMANS

Zenodo (CERN European Organization for Nuclear Research)
Hormonal and reproductive studies
article

ADVERSE EFFECTS OF TRENBOLONE: A STRUCTURED REVIEW OF CASE REPORTS IN HUMANS

article en

Abstract

Introduction: Trenbolone is a potent anabolic steroid widely used in bodybuilding, despite its lack of approval for human use. Reports of adverse effects have increased, but systematic data on its health risks remain limited. This study aims to systematically review documented adverse effects of trenbolone in humans through published case reports. Methods: A structured review of case reports was conducted using PubMed, EMBASE, and CENTRAL databases, including studies up to 2024. The search strategy utilized Medical Subject Headings (MeSH) terms related to trenbolone. Inclusion criteria encompassed reports of adverse effects in humans with documented trenbolone use, while experimental studies, animal models, and reviews without original case data were excluded. Extracted data included patient demographics, trenbolone dosage, administration patterns, clinical presentation, toxicological findings, and affected organ systems. Results: A total of 23 case reports met the inclusion criteria. The most frequently reported complications involved the cardiovascular system (heart failure, myocardial infarction, ischemic stroke), hepatic system (cholestatic liver injury, hepatitis), renal system (nephropathy, acute kidney injury), and neuropsychiatric effects (psychosis, aggression, delirium). Most cases involved young male users, with trenbolone frequently sourced from unregulated markets. Toxicological confirmation was reported in only a minority of cases, complicating causality assessment. Conclusion: Trenbolone use is associated with severe health risks, particularly affecting the cardiovascular, hepatic, renal, and neuropsychiatric systems. The absence of clinical studies on its safety, along with widespread unregulated use, hinders risk assessment and patient management. Healthcare professionals should recognize potential adverse effects, promoting early detection and harm reduction. Further research is needed to clarify trenbolone’s long-term impact on human health.

Zenodo (CERN European Organization for Nuclear Research)
Center for Health, Exercise and Sport Sciences (RS), Governo do Estado de São Paulo (BR)
Good health and well-being
Openalex Percentile: Top 44%
Hormonal and reproductive studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ADVERSE EFFECTS OF TRENBOLONE: A STRUCTURED REVIEW OF CASE REPORTS IN HUMANS · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS